Target RNA nucleic acid molecule detection method based on Cas protein

By adding a specific sequence at the 5' end of the RNA sequence to bind to the Cas12a protein, the cleavage activity of PAM-independent sites is achieved, and the problems of complex and low sensitivity of RNA diagnostic methods in the prior art are solved, and efficient and stable RNA detection.

CN118910223APending Publication Date: 2024-11-08SHANGHAI GUANLU MEDICAL EQUIPMENT TECHNOLOGY CO LTD
View PDF 0 Cites 3 Cited by

Patent Information

Application Number
CN202310512599.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2023-05-08
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

The diagnostic methods of RNA viruses in the prior art are complex and have low sensitivity, and the detection methods based on Cas12 protein rely on PAM sites, are inefficient and difficult to effectively detect RNA molecules.

Method used

By adding a specific sequence at the 5' end of the target RNA sequence, it binds to the Cas12a protein, cleavage activity of PAM-independent sites is achieved, and a fluorescence signal is generated for detection.

Benefits of technology

Direct, fast and highly sensitive RNA detection is achieved, reducing detection complexity and contamination risks, and improving the storage and transportation stability of reagents.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118910223A_ABST
    Figure CN118910223A_ABST
Patent Text Reader

Abstract

The invention discloses a non-diagnostic target RNA nucleic acid molecule detection method, which comprises the following steps: carrying out reverse transcription and transcription amplification on a to-be-detected RNA sample; a specific upstream primer is designed to add a section of specific sequence at the 5'end of a target RNA sequence to obtain tailed RNA containing the specific sequence, the tailed RNA is specifically combined with Cas12a, the Cas12a plays a role in cleavage activity, and DNA is reported to generate a detectable fluorescence signal through specific cleavage. The detection method provided by the invention breaks through the limitation that the classical Cas12a protein can only detect the DNA target and needs a PAM site, and can quickly detect whether the sample to be detected contains the target RNA sequence or not.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the field of genetic engineering technology, and specifically relates to a nucleic acid detection method based on the CRISPR system, and specifically relates to a detection method for target RNA nucleic acid molecules based on the Cas protein. Background Art

[0002] Specific nucleic acid molecule detection methods have important application value. Since each pathogen microorganism has its own unique characteristic nucleic acid molecule sequence, it is possible to develop nucleic acid molecule detection for specific species, also known as nucleic acid diagnosis. Currently established nucleic acid diagnostic methods are mainly for the detection of specific DNA molecules, and there are few methods for RNA molecules. Generally speaking, DNA molecules are stable, while RNA is very easy to degrade and difficult to operate and handle.

[0003] In recent years, the world has faced severe challenges in controlling the spread of RNA viruses. SARS-CoV-2 and many other RNA viruses spread rapidly, partly due to the high prevalence of presymptomatic and asymptomatic transmission. Therefore, the diagnosis of RNA viruses is crucial so that intervention can be carried out quickly after diagnosis is confirmed.

[0004] Currently, reverse transcription quantitative real-time PCR (RT-qPCR)-based testing is the gold standard for viral diagnosis. This technology requires skilled operators and equipment facilities, and the sample response time is long. Isothermal amplification analysis, such as recombinase polymerase amplification (RPA) and loop-mediated isothermal amplification (LAMP), provides a fast and low-cost alternative. Abbott's ID NOW 2019 coronavirus test reagent, which uses isothermal amplification to test unextracted samples, can report results within 13 minutes, but in comparison with samples that tested positive by RT-qPCR, one-third to 45% of the test results were negative. In addition, isothermal amplification reagents often introduce nonspecific amplification, which can also lead to false positive results.

[0005] CRISPR-Cas protein is an RNA-guided endonuclease used to cut specific nucleic acid sequences, a process called cis cutting. After recognizing the sequence, Cas12 and Cas13 proteins show the side effect of cutting non-target single strands (Cas12 recognizes ssDNA, Cas13 recognizes ssRNA), a process called trans cutting. In the past, Cas12 family member proteins combined with crRNA recognized amplified double-stranded DNA with PAM sites, and then trans-cut reporter molecules to produce Cas12a-based DETECTR and Cas12b-based HOLMES technology.

[0006] However, whether it is RT-qPCR, DETECTR, or HOLMES, reverse transcription must first be performed, and then the reverse transcribed cDNA must be enriched and amplified. The double-stranded DNA sequence that is used as a QPCR probe or the substrate recognized by Cas12 is amplified, which increases the complexity. In addition, the multiple opening operations based on Cas recognition technology will also increase the possibility of DNA contamination of PCR products, and the presence of guide RNA in the reagents puts higher requirements on the transportation and storage of the reagents. If the transportation and storage are not in appropriate conditions, the detection reagents will easily lose their effectiveness.

[0007] In addition, the current method for detecting target nucleic acid molecules based on Cas12 protein cannot be separated from the PAM site in its design area. If it is not the preferred PAM, the efficiency of the entire reaction system is very low or even cannot work effectively. Its detection limit and sensitivity are greatly inferior to those of traditional RT-qPCR. Summary of the invention

[0008] In view of the above-mentioned technical problems in the prior art, the present invention provides a method for detecting a target RNA nucleic acid molecule using Cas12 protein, and the method for detecting RNA using Cas12a protein solves the defects of the prior art method for detecting RNA molecules, such as complexity, low sensitivity and low specificity, and gets rid of the limitation that the conventional Cas12a protein relies on the PAM site to perform the cutting effect.

[0009] The present invention includes the following technical solutions:

[0010] In the first aspect, the present invention provides a method for detecting a target RNA nucleic acid molecule for non-diagnostic purposes, characterized in that the method comprises reverse transcription and transcription amplification of the RNA sample to be tested, adding a specific sequence to the 5' end of the target RNA sequence, wherein the specific sequence is partially or completely identical to the dr sequence of Cas12a, so that the tailed RNA containing the specific sequence specifically binds to Cas12a, Cas12a exerts cutting activity, and specifically cuts the reporter DNA to produce a detectable fluorescent signal.

[0011] In a specific embodiment of the present invention, the specific sequence is one of the following sequences:

[0012] a) GUAGAU;

[0013] b)CUUGUAGAU;

[0014] c)UAAUUCUACUCUUUGUAGAU.

[0015] The numbers of the above sequences are SEQ NO: 9, SEQ NO: 10, and SEQ NO: 11 respectively.

[0016] The reporter DNA of the present invention specifically hybridizes with the target RNA nucleic acid sequence or the complementary sequence of the target RNA nucleic acid sequence. The reporter DNA molecule length is 2-100 nucleotides, preferably 10-20 nucleotides.

[0017] The reporter DNA of the present invention is fluorescently labeled DNA. Furthermore, the 5' end of the DNA is labeled with a fluorescent group, and the 3' end is labeled with a quenching group. In a specific embodiment of the present invention, the fluorescent group is selected from FAM, TEX, HEX, Cy3 or Cy5, and the quenching group is selected from BHQ1, BHQ2, BHQ3 or TAMRA. When the reporter DNA is cut off, the quenching group no longer absorbs the luminescent group, and a substantial increase in fluorescence intensity can be detected.

[0018] The RNA sample to be tested is total RNA extracted from whole blood, serum, plasma, cerebrospinal fluid, urine, feces, cells or tissues.

[0019] The Cas12a described in the present invention is selected from one of LbCas12a, FnCas12a, AsCas12a, Lb5Cas12a, HkCas12a, OsCas12a, TsCas12a, BbCas12a, BoCas12a, and Lb4Cas12a, or a Cas protein with similar cis-cleavage activity to Cas12a.

[0020] Preferably, the Cas12a is LbCas12a or FnCas12a.

[0021] Preferably, the present invention adds a specific sequence to the 5' end of the target RNA sequence by designing a specific upstream primer, wherein the specific upstream primer sequence contains one of the following sequences:

[0022] a) GTAGAT;

[0023] b) CTTGTAGAT;

[0024] c)TAATTCTACTCTTTGTAGAT.

[0025] The numbers of the above sequences are SEQ NO: 12, SEQ NO: 13, and SEQ NO: 14 respectively.

[0026] Furthermore, the specific upstream primer sequence also includes a transcriptase recognition region, such as a promoter sequence of T7 or Sp6.

[0027] In the most preferred embodiment of the present invention, the method for detecting the target RNA nucleic acid molecule for non-diagnostic purposes comprises the following steps:

[0028] (1) adding specific upstream primers and downstream primers to a system containing a target RNA nucleic acid molecule to be detected for reverse transcription and transcription amplification to obtain a tailed RNA containing a specific sequence at the 5' end;

[0029] (2) contacting the tailing RNA containing a specific sequence with Cas12a and the reporter DNA that generates a detection signal after being cut to form a Cas12a-tailing RNA-reporter DNA ternary complex;

[0030] (3) Detecting the presence and / or level of a detectable signal generated in the reaction system.

[0031] The downstream primer is a sequence with reverse transcription and transcription amplification functions that can be designed by those skilled in the art based on the existing technology.

[0032] The present invention has no particular restrictions on the transcription amplification method, and those skilled in the art can select it as needed. Specifically, the amplification method includes but is not limited to PCR amplification, LAMP amplification, TMA, RPA amplification, NASBA, SDA, transcription-mediated amplification, rolling circle amplification, HAD, SPIA, NEAR. In a preferred embodiment of the present invention, the amplification method is TMA, NASBA.

[0033] The target RNA nucleic acid molecule detection method provided by the present invention can detect RNA molecules from different sources, such as RNA molecules from mammals, plants, microorganisms, and viruses.

[0034] In a second aspect, the present invention provides a detection kit for detecting a target RNA nucleic acid molecule, characterized in that the kit comprises:

[0035] (1) A primer pair for reverse transcription and transcription amplification of a target nucleic acid molecule, wherein the upstream primer sequence of the primer pair comprises one of the following sequences:

[0036] a) GTAGAT;

[0037] b) CTTGTAGAT;

[0038] c)TAATTCTACTCTTTGTAGAT;

[0039] (2) Cas12a protein;

[0040] (3) reporter DNA that produces a detectable signal after cleavage;

[0041] (4) optional enzymes and dNTPs for reverse transcription and amplification;

[0042] The downstream primers used for reverse transcription and transcription amplification of the target nucleic acid molecule in the kit are sequences with reverse transcription and transcription amplification functions that can be designed by those skilled in the art based on the prior art.

[0043] Preferably, the kit provided by the present invention also includes a buffer for the reaction, including but not limited to NEBuffer TM 2. NEBuffe TM 2.1 or Buffer.

[0044] A target RNA nucleic acid molecule detection method based on Cas protein provided by the present invention, the detection principle is as follows: the present invention designs upstream and downstream primers with reverse transcription and transcription amplification functions according to the target RNA sequence, if the target RNA sequence is contained in the RNA molecule to be detected, the enriched DNA template will be amplified after adding the primer, and then the tailing RNA containing the specific sequence is synthesized by T7 transcriptase. The composition of the tailing RNA is actually a specific sequence added to the 5' end of the target RNA, and the specific sequence is partially or entirely identical to the dr sequence in the crRNA specifically identified by Cas12a, so the tailing RNA can be specifically combined with Cas12a. Therefore, when the target RNA to be detected exists, Cas12a forms a ternary complex with the tailing RNA and the reporter DNA, and the Cas12a protein performs its cutting activity, cuts the reporter DNA with a fluorescent label, and the reporter DNA luminescent group after being cut off emits fluorescence. Therefore, by detecting fluorescence, it can be known whether the target RNA molecule is contained in the system to be detected.

[0045] In the target RNA nucleic acid molecule detection method based on Cas12a protein provided by the present invention, the cutting mode of Cas12a to fluorescent reporter DNA is a programmed cutting mode that is independent of the PAM sequence, which is cis-cutting. In the reaction system, once Cas12a-containing RNA-reporter DNA with specific sequence forms a ternary complex, Cas12a protein will show cutting activity, cut the reporter DNA, and emit a fluorescent detectable signal.

[0046] The detection method provided by the present invention has the following advantages:

[0047] The detection system provided by the present invention can directly detect RNA, that is, the detection object is RNA, breaking through the limitation that the classic Cas12a protein can only detect DNA targets, and can quickly detect whether the sample to be tested contains the target RNA sequence.

[0048] The present invention uses RNA as the detection target, so that the entire detection system is free from the limitation of PAM sites required in classical Cas cleavage, and because the RNA that generates the ternary complex is generated in real time, no pre-synthesis and strict storage conditions are required. Therefore, the storage stability and transportation stability of the system provided by the present invention are greatly improved, and the production cost is reduced to a certain extent.

[0049] The fluorescently labeled reporter DNA used in the present invention may be not only single-stranded DNA but also double-stranded DNA. BRIEF DESCRIPTION OF THE DRAWINGS

[0050] Figure 1 Schematic diagram of the detection principle of target RNA nucleic acid molecules.

[0051] Figure 2 Fluorescence signal diagram of Example 1.

[0052] Figure 3 Fluorescence signal diagram of Example 2. DETAILED DESCRIPTION

[0053] The technical solutions in the embodiments of the present invention are described clearly and completely below. Obviously, the described embodiments are only some embodiments of the present invention, not all. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0054] The relevant terms involved in the present invention are described as follows:

[0055] "CRISPR-Cas" is a unique genomic element derived from bacteria and archaea, which serves as an adaptive immune defense system to resist invading phages or foreign nucleic acids. The system consists of clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated proteins (abbreviated as Cas proteins, Cas).

[0056] "Cas protein" refers to CRISPR-associated protein, which is a related protein in the CRISPR system.

[0057] "Cas12a" (formerly known as "Cpf1") refers to a crRNA-dependent endonuclease, which is a type VA enzyme in the CRISPR system classification.

[0058] An "RNA target molecule" is a region of RNA to be detected.

[0059] "Cas12a DR sequence" refers to the removal of base information for a specific DNA sequence in the crRNA of Cas12a. After recognizing the PAM (Protspacer adjacent motif) sequence adjacent to the target DNA, the Cas12a protein realizes the cutting function through the complementarity between crRNA and the target sequence. The DR sequence of Cas 12a itself forms an arch fold, and the DR sequence function of Cas 12a is related to Cas12a recognition and binding crRNA.

[0060] The biological techniques used in the present invention include RNA amplification related techniques, such as TMA, NASBA, SMART, RT-PCR, RT-LAMP, RT-RPA followed by T7 transcription to generate the required tailed RNA in real time.

[0061] Example 1 Cas12a protein detects target RNA (GSTM1)

[0062] Select GSTM1 as the target RNA sequence and test the response value of Cas12a protein LbCas12a to its detection. In order to simplify the experimental procedure, the inventor synthesized the GSTM1 target sequence as the nucleic acid to be detected.

[0063] Specific steps:

[0064] S1: Prepare the first system: LbCas12a (100 μM): 0.1 μL; reporter DNA (100 nM): 5 μL; NEBBuffer TM 2.1 (purchased from New England Biolabs): 2 μL. The above systems were mixed into a 10 μL mixture (the insufficient part was supplemented with water) as the first system.

[0065] Preparation of S2 tailed RNA: Using GSTM1 as template (nucleic acid to be detected), Primer-001 and Primer-002 as upstream and downstream primers, one-step reverse transcription PCR was performed, and the product was synthesized into tailed RNA using T7 transcriptase.

[0066] One-step reverse transcription reaction was performed using GSTM1 shown in Table 1 as a template. Specifically, the following reaction components were added to a reaction tube containing 1 μg of GSTM1 in order: 1 μL of Primer-001 and Primer-002 primers, 2 μL of 10×RTPCRmix (Takara), 1 μL of RNase inhibitor, 1 μL of reverse transcriptase, and 20 μL of RNase-free ddH2O was added. The reaction was performed at 50°C for 5 min. PCR cycles were then performed: 95°C for 2 min, (95°C for 20 s, 60°C for 40 s) for 35 cycles. After the reaction, 2 μL of the product was taken and tailed RNA was synthesized using T7 enzyme.

[0067] S3: Take 4 μL of the tailed RNA product and mix it with the first system.

[0068] S4 fluorescence detection: Set ABI Qs3 at 37°C for 30 seconds per time to collect FAM channel fluorescence, and cycle for 5 minutes.

[0069] At the same time, a control experiment (NTC) was set up in parallel with Example 1, and the operation steps were as follows:

[0070] S1 prepares the first system: LbCas12a (100 μM): 0.1 μL; reporter DNA-1 (100 nM): 5 μL; NEBBuffer TM 2.1 (purchased from New England Biolabs): 2 μL. The above systems were mixed into a 10 μL mixture (the insufficient part was supplemented with water) as the first system.

[0071] S2: Replace GSTM1 (test nucleic acid) with human influenza A RNA reference of equal mass, use Primer-001 and Primer-002 as upstream and downstream primers, perform one-step RT-PCR for reverse transcription, and then transcribe with T7 transcriptase. The specific operation method is the same as above. Take 4 μL of step S2 product and mix it with the first system.

[0072] S3 fluorescence detection: Set ABI Qs3 at 37°C for 30 seconds per time to collect FAM channel fluorescence, and cycle for 5 minutes for detection.

[0073] Table 1 Nucleic acid sequences involved in Example 1

[0074]

[0075] The results are as follows Figure 2 As shown in Example 1, when RNA to be detected (GSTM1) exists, adding the upstream and downstream primers provided by the present invention will produce tailing RNA, tailing RNA-Cas12a-report DNA ternary complex formation, Cas12a cuts the reporter DNA, and the fluorescence curve has a significant increment. When the RNA to be detected is a human first-stream RNA sequence, the upstream and downstream primers described in Example 1 are added to form tailing RNA, and the tailing RNA-Cas12a-report DNA ternary complex cannot be formed, and the reporter DNA remains intact, and no fluorescent signal is generated.

[0076] Example 2 Cas12a protein detects target RNA (CovidN)

[0077] CovidN was selected as the target RNA sequence to test the response value of Cas12a protein LbCas12a to CovidN target RNA detection. In order to simplify the experimental procedure, the inventor synthesized the CovidN target sequence as the nucleic acid to be detected.

[0078] Specific steps:

[0079] S1 prepares the first system: LbCas12a (100 μM): 0.1 μL; reporter DNA-2 (100 nM): 5 μL; NEBBuffer TM 2.1 (purchased from New England Biolabs): 2 μL. The above systems were mixed into a 10 μL mixture (the insufficient part was supplemented with water) as the first system.

[0080] Preparation of S2 tailed RNA: CovidN was used as the template (nucleic acid to be detected), and Nasba-001 and Nasba-002 were used as upstream and downstream primers to synthesize tailed RNA.

[0081] Specific method: prepare TMA buffer (120mM Tris-HCl, pH 8.5, 210mM ​​KCl, 36mM MgCl2, 30mM DTT, 45% DMSO), 10× enzyme premix (200U / ul T7 reverse transcriptase, 10U / μL M-MLV), add 1μL CovidN (Shanghai Institute of Metrology standard), 1μL Nasba-001 and Nasba-002 primers, 7μL TMA buffer, 2μL enzyme premix, 8μL ddH2O to the system to make TMA reaction solution, react at 42°C for 90min, and synthesize tailed RNA.

[0082] S3: Take 2 μL of the tailed RNA product and mix it with the first system.

[0083] S4 fluorescence detection: Set ABI Qs3 at 37°C for 30 seconds per time to collect FAM channel fluorescence, and cycle for 5 minutes.

[0084] At the same time, a set of control experiments (NTC-LbCas12a) parallel to Example 2 was set up, and the operation steps were as follows:

[0085] S1 Prepare the first system: LbCas12a (100 μM): 0.1 μL; Reporter DNA-2 (100 nM): 5 μL; NEBBuffer TM 2.1 (purchased from New England Biolabs): 2 μL. The above systems were mixed into a 10 μL mixture (the insufficient part was supplemented with water) as the first system.

[0086] S2: Replace CovidN (the nucleic acid to be tested) with a human influenza A RNA reference of equal quality, use Nasba-001 and Nasba-002 as upstream and downstream primers, and follow the same procedures for reverse transcription and transcription amplification.

[0087] S3 fluorescence detection: Set ABI Qs3 at 37°C for 30 seconds per time to collect FAM channel fluorescence, and cycle for 5 minutes for detection.

[0088] Table 2 Nucleic acid sequences involved in Example 2

[0089]

[0090] CovidN was selected as the target RNA sequence to test the response value of Cas12a protein FnCas12a to CovidN target RNA detection. The detection system and the nucleic acids involved were the same as those in Example 2, except that LbCas12a (100 μM): 0.1 μL in Example 2 was replaced with FnCas12a (100 μM): 0.1 μL. At the same time, a set of corresponding control experiments (NTC-FnCas12a) was set up.

[0091] The test results of Example 2 are as follows Figure 3 As shown, when there is a target RNA (CovidN) in the system, the addition of the upstream and downstream primers described in Table 2 will produce tailing RNA, tailing RNA-Cas12a-report DNA ternary complex formation, Cas12a cuts the reporter DNA, and the fluorescence curve has a significant increment. If there is no target RNA (CovidN) in the system, the addition of the above-mentioned upstream and downstream primers will not produce tailing RNA, and the tailing RNA-Cas12a-report DNA ternary complex cannot be formed, Cas12a cannot exert its cutting activity, the reporter nucleic acid remains intact, and no signal is generated.

[0092] Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention, rather than to limit it. Although the present invention has been described in detail with reference to the aforementioned embodiments, those skilled in the art should understand that they can still modify the technical solutions described in the aforementioned embodiments, or replace some or all of the technical features therein with equivalents. However, these modifications or replacements do not cause the essence of the corresponding technical solutions to deviate from the scope of the technical solutions of the embodiments of the present invention.

Claims

1. A method for detecting a target RNA nucleic acid molecule for non-diagnostic purposes, characterized in that: The method comprises reverse transcription and transcription amplification of the RNA sample to be tested, adding a specific sequence to the 5' end of the target RNA sequence, wherein the specific sequence is partially or completely identical to the dr sequence of Cas12a, so that the tailed RNA containing the specific sequence specifically binds to Cas12a, Cas12a exerts cutting activity, and specifically cuts the reporter DNA to generate a detectable fluorescent signal.

2. The detection method according to claim 1, characterized in that: The specific sequence is one of the following sequences: a) GUAGAU; b)CUUGUAGAU; c)UAAUUCUACUCUUUGUAGAU.

3. The detection method according to claim 1, characterized in that: The reporter DNA specifically hybridizes with the target RNA nucleic acid sequence or the complementary sequence of the target RNA nucleic acid sequence, and the length of the reporter DNA molecule is 2-100 nucleotides.

4. The detection method according to claim 1, characterized in that: The reporter DNA is fluorescently labeled DNA, the 5' end of the DNA is labeled with a fluorescent group, and the 3' end is labeled with a quenching group; the fluorescent group is selected from FAM, TEX, HEX, Cy3 or Cy5, and the quenching group is selected from BHQ1, BHQ2, BHQ3 or TAMRA.

5. The detection method according to claim 1, characterized in that: The RNA sample to be tested is total RNA extracted from whole blood, serum, plasma, cerebrospinal fluid, urine, feces, cells or tissues.

6. The detection method according to claim 1, characterized in that: The Cas12a is selected from one of LbCas12a, FnCas12a, AsCas12a, Lb5Cas12a, HkCas12a, OsCas12a, TsCas12a, BbCas12a, BoCas12a, and Lb4Cas12a, or a Cas protein with similar cis-cleavage activity to Cas12a.

7. The detection method according to claim 1, characterized in that: A specific sequence is added to the 5' end of the target RNA sequence by designing a specific upstream primer, wherein the specific upstream primer sequence contains one of the following sequences: a) GTAGAT; b) CTTGTAGAT; c)TAATTCTACTCTTTGTAGAT.

8. The detection method according to claim 7, characterized in that: The specific upstream primer sequence also includes a transcriptase recognition region, including a promoter sequence of T7 or Sp6.

9. The detection method according to claim 1, characterized in that: The method for detecting the target RNA nucleic acid molecule for non-diagnostic purposes comprises the following steps: (1) adding specific upstream primers and downstream primers to a system containing a target RNA nucleic acid molecule to be detected for reverse transcription and transcription amplification to obtain a tailed RNA containing a specific sequence at the 5' end; (2) contacting the tailing RNA containing a specific sequence with Cas12a and the reporter DNA that generates a detection signal after being cut to form a Cas12a-tailing RNA-reporter DNA ternary complex; (3) Detecting the presence and / or level of a detectable signal generated in the reaction system.

10. A detection kit for detecting a target RNA nucleic acid molecule, characterized in that: The kit comprises: (1) A primer pair for reverse transcription and transcription amplification of a target nucleic acid molecule, wherein the upstream primer sequence of the primer pair comprises one of the following sequences: a) GTAGAT; b) CTTGTAGAT; c)TAATTCTACTCTTTGTAGAT; (2) Cas12a protein; (3) reporter DNA that produces a detectable signal after cleavage; (4) optional enzymes and dNTPs for reverse transcription and amplification; The kit also includes a buffer for the reaction.

Citation Information

Cited By

  • Polynucleotide detection method, kit and application

    CN120006042A

  • Multiple TMA-CRISPR kit aiming at respiratory pathogen RNA and application of multiple TMA-CRISPR kit

    CN121109659A

  • A Multiplex TMA-CRISPR Kit for Respiratory Pathogen RNA and Its Application

    CN121109659B